I have a dear friend who had cancer. I guess you could say she still does, but thanks to Gleevec, the world’s first targeted cancer therapy, she’s alive and well today.
So any time I get to tell the story of Gleevec, or of those it helps, it’s personal. That’s why I love this story about Katie, who was diagnosed with cancer when she was six. Fifteen years later, at 21, she’s a dancer, coach, and student.
Working with Gard Communications and the OHSU Foundation, we photographed Katie and a few others who started on Gleevec when it was developed 15 years ago. It was something of a moving experience, to work with people who are alive and thriving today, just like my friend, thanks to a treatment developed right here in Portland.